Yangming Zhang

2.7k total citations
57 papers, 1.3k citations indexed

About

Yangming Zhang is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Yangming Zhang has authored 57 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Epidemiology. Recurrent topics in Yangming Zhang's work include Histone Deacetylase Inhibitors Research (7 papers), Protein Degradation and Inhibitors (5 papers) and Peptidase Inhibition and Analysis (4 papers). Yangming Zhang is often cited by papers focused on Histone Deacetylase Inhibitors Research (7 papers), Protein Degradation and Inhibitors (5 papers) and Peptidase Inhibition and Analysis (4 papers). Yangming Zhang collaborates with scholars based in China, United States and Romania. Yangming Zhang's co-authors include Fajun Nan, Changtao Jiang, Yanli Pang, Huiying Liu, Jingya Li, Pengcheng Wang, Qing Wu, Shichao Cui, Lulu Sun and Wei Kong and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Angewandte Chemie International Edition.

In The Last Decade

Yangming Zhang

52 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yangming Zhang China 20 619 190 155 138 119 57 1.3k
Jian Hou China 25 764 1.2× 116 0.6× 71 0.5× 123 0.9× 134 1.1× 92 1.7k
Hongliang Xu China 21 659 1.1× 203 1.1× 78 0.5× 262 1.9× 148 1.2× 62 1.4k
Hong Xiao China 25 742 1.2× 156 0.8× 100 0.6× 112 0.8× 273 2.3× 83 1.7k
Ming‐Wei Lin Taiwan 24 734 1.2× 115 0.6× 67 0.4× 65 0.5× 161 1.4× 70 1.4k
Xiaoming Yang China 25 898 1.5× 147 0.8× 154 1.0× 177 1.3× 107 0.9× 72 1.7k
Meng Sun China 19 565 0.9× 127 0.7× 97 0.6× 126 0.9× 153 1.3× 49 1.3k
Nir Qvit United States 17 1.4k 2.3× 199 1.0× 154 1.0× 242 1.8× 88 0.7× 45 1.8k
Tania Gamberi Italy 26 666 1.1× 160 0.8× 312 2.0× 251 1.8× 103 0.9× 82 1.6k
Lokesh Kumar Bhatt India 22 599 1.0× 116 0.6× 55 0.4× 162 1.2× 138 1.2× 89 1.6k

Countries citing papers authored by Yangming Zhang

Since Specialization
Citations

This map shows the geographic impact of Yangming Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yangming Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yangming Zhang more than expected).

Fields of papers citing papers by Yangming Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yangming Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yangming Zhang. The network helps show where Yangming Zhang may publish in the future.

Co-authorship network of co-authors of Yangming Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Yangming Zhang. A scholar is included among the top collaborators of Yangming Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yangming Zhang. Yangming Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Niu, Jun, Xiaoyan Zhu, Ge Zhang, et al.. (2025). Comparing Different Membership Inference Attacks With a Comprehensive Benchmark. IEEE Transactions on Information Forensics and Security. 20. 6592–6606. 1 indexed citations
3.
Wang, Xinran, Pablo Cruz‐Morales, Biming Zhong, et al.. (2024). Elucidation of genes enhancing natural product biosynthesis through co-evolution analysis. Nature Metabolism. 6(5). 933–946. 18 indexed citations
4.
Liu, Xinjing, Mei Zhang, Zhifu Xie, et al.. (2024). Simultaneous determination of BGT-002 and its acyl glucuronide metabolite ZM326E-M2 in human plasma by liquid chromatography-tandem mass spectrometry and its application to a pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis. 243. 116056–116056. 1 indexed citations
5.
Li, Xuezhao, Xing Zhao, Wen Wang, et al.. (2023). Biomedical applications of multinuclear Pt(II)/Ru(II)/Ir(III) metallo-supramolecular assemblies for intensive cancer therapy. Coordination Chemistry Reviews. 495. 215366–215366. 21 indexed citations
6.
Wang, Siwei, Qing Zhang, Dan Lu, et al.. (2023). GPR84 regulates pulmonary inflammation by modulating neutrophil functions. Acta Pharmacologica Sinica. 44(8). 1665–1675. 29 indexed citations
7.
Liu, Mingyue, et al.. (2023). Targeting Mitochondrial Sirtuins in Age-Related Neurodegenerative Diseases and Fibrosis. Aging and Disease. 14(5). 1583–1583. 16 indexed citations
8.
Xie, Zhifu, Mei Zhang, Qian Song, et al.. (2022). Development of the novel ACLY inhibitor 326E as a promising treatment for hypercholesterolemia. Acta Pharmaceutica Sinica B. 13(2). 739–753. 32 indexed citations
9.
He, Ting, Yinglei Gao, Yanfen Fang, et al.. (2022). The HDAC inhibitor GCJ-490A suppresses c-Met expression through IKKα and overcomes gefitinib resistance in non-small cell lung cancer. Cancer Biology and Medicine. 19(8). 1172–1192. 11 indexed citations
10.
Chen, Zhuhong, Yuting Li, Chi Zhang, et al.. (2022). The brain structure and function abnormalities of migraineurs: A systematic review and neuroimaging meta-analysis. Frontiers in Neurology. 13. 1022793–1022793. 14 indexed citations
11.
Zhang, Qing, Linhai Chen, Hui Yang, et al.. (2021). GPR84 signaling promotes intestinal mucosal inflammation via enhancing NLRP3 inflammasome activation in macrophages. Acta Pharmacologica Sinica. 43(8). 2042–2054. 51 indexed citations
12.
Zhou, Yubo, Yangming Zhang, Honghui Huang, et al.. (2021). Pharmacodynamic, pharmacokinetic, and phase 1a study of bisthianostat, a novel histone deacetylase inhibitor, for the treatment of relapsed or refractory multiple myeloma. Acta Pharmacologica Sinica. 43(4). 1091–1099. 9 indexed citations
13.
Zhang, Yangming, Fei Xing, Rong Luo, & Xin Duan. (2021). Platelet-Rich Plasma for Bone Fracture Treatment: A Systematic Review of Current Evidence in Preclinical and Clinical Studies. Frontiers in Medicine. 8. 676033–676033. 29 indexed citations
14.
Zhang, Yangming, Xiaohui Zhao, & Zan Li. (2020). Facilitated and Enhanced Human Activity Recognition via Semi-supervised LightGBM. 1–6. 6 indexed citations
15.
Lian, Guan, Xiaopeng Li, Linqi Zhang, et al.. (2019). Macrophage metabolic reprogramming aggravates aortic dissection through the HIF1α-ADAM17 pathway✰. EBioMedicine. 49. 291–304. 101 indexed citations
16.
Zhang, Mei, Zhifu Xie, Min Ji Gu, et al.. (2018). Novel substituted pyrazolone derivatives as AMP-activated protein kinase activators to inhibit lipid synthesis and reduce lipid accumulation in ob/ob mice. Acta Pharmacologica Sinica. 39(10). 1622–1632. 8 indexed citations
17.
Yang, Li, Yajuan Wang, Haijun Chen, et al.. (2015). Effect of a hepatitis B virus inhibitor, NZ-4, on capsid formation. Antiviral Research. 125. 25–33. 29 indexed citations
18.
Cui, Jin, Xiaoyin Wang, Xiaohang Li, et al.. (2015). Targeting the γ-/β-secretase interaction reduces β-amyloid generation and ameliorates Alzheimer’s disease-related pathogenesis. Cell Discovery. 1(1). 15021–15021. 30 indexed citations
19.
Zhou, Pingzheng, Yangming Zhang, Haiyan Xu, et al.. (2014). P-Retigabine: An N-Propargyled Retigabine with Improved Brain Distribution and Enhanced Antiepileptic Activity. Molecular Pharmacology. 87(1). 31–38. 13 indexed citations
20.
Zhang, Yangming, Yu Ding, Wei Tang, et al.. (2008). Synthesis and biological evaluation of immunosuppressive agent DZ2002 and its stereoisomers. Bioorganic & Medicinal Chemistry. 16(20). 9212–9216. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jian Hou Breakdown of academic impact, for papers by Hongliang Xu Breakdown of academic impact, for papers by Hong Xiao Breakdown of academic impact, for papers by Ming‐Wei Lin Breakdown of academic impact, for papers by Xiaoming Yang Breakdown of academic impact, for papers by Meng Sun Breakdown of academic impact, for papers by Nir Qvit Breakdown of academic impact, for papers by Tania Gamberi Breakdown of academic impact, for papers by Lokesh Kumar Bhatt
Rankless by CCL
2026